Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDTY.L Regulatory News (DTY)

  • There is currently no data for DTY

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - DIGNITY PLC

20 Apr 2023 10:52

RNS Number : 9273W
Barclays PLC
20 April 2023
 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

 

Barclays PLC.

(b)

Owner or controller of interest and short

 

 

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

DIGNITY PLC

 

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

 

 

offeror/offeree, state this and specify identity of

 

offeror/offeree:

(e)

Date position held/dealing undertaken:

19 Apr 2023

(f)

In addition to the company in 1(c) above, is the discloser making

No:

 

 

 

disclosures in respect of any other party to the offer?

CASTELNAU GROUP LTD

 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

 

 

to which the disclosure relates following the dealing(if any)

 

Class of relevant security:

12 48/143p ordinary

 

Interests

Short Positions

 

Number

(%)

Number

(%)

(1)

Relevant securities owned

 

 

 

 

 

and/or controlled:

 

 

685,539

1.37%

25,647

0.05%

(2)

Cash-settled derivatives:

 

 

 

 

 

and/or controlled:

 

 

129,816

0.26%

680,075

1.36%

(3)

Stock-settled derivatives (including options)

 

 

 

 

 

and agreements to purchase/sell:

 

 

0

0.00%

0

0.00%

 

 

 

 

 

 

 

 

 

TOTAL:

 

 

815,355

1.63%

705,722

1.41%

(b)

Rights to subscribe for new securities (including directors and other executive

 

 

options)

 

 

 

 

 

 

Class of relevant security in relation to

 

 

 

 

which subscription right exists

 

 

 

 

Details, including nature of the rights

 

 

 

 

concerned and relevant percentages:

 

 

 

 

3.

DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

(a)

Purchases and sales

 

 

 

 

 

Class of relevant

Purchase/sale

Number of

Price per unit

security

 

securities

 

12 48/143p ordinary

Purchase

287

5.4997 GBP

12 48/143p ordinary

Purchase

1,155

5.4900 GBP

12 48/143p ordinary

Purchase

2,156

5.5082 GBP

12 48/143p ordinary

Sale

287

5.5000 GBP

12 48/143p ordinary

Sale

1,155

5.4900 GBP

 

 

 

 

 

 

 

 

(b)

Cash-settled derivative transactions

 

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

 

reference

unit

security

 

 

securities

 

12 48/143p ordinary

SWAP

Short

2,156

5.5082 GBP

 

 

 

 

 

 

 

 

(c)

Stock-settled derivative transactions (including options)

 

(i)

Writing, selling, purchasing or varying

 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

 

date

money

relevant

 

selling,

securities

per unit

 

 

paid/

security

 

varying etc

to which

 

 

 

received

 

 

 

option

 

 

 

per unit

 

 

 

relates

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(ii)

Exercising

 

 

 

 

 

 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

 

 

securities

unit

 

 

 

 

 

 

 

 

 

 

 

 

 

(d)

Other dealings (including subscribing for new securities)

 

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

 

 

applicable)

 

 

 

 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding,

 

 

formal or informal, relating to relevant securities which may be an inducement to deal

 

 

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

 

to the offer or any person acting in concert with a party to the offer:

 

 

 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between

 

 

the person making the disclosure and any other person relating to:

 

 

(i) the voting rights of any relevant securities under any option; or

 

 

 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

 

 

any derivative is referenced:

 

 

 

 

 

 

NONE

(c)

Attachments

 

 

 

 

 

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

20 Apr 2023

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETFIFEASIIIFIV
Date   Source Headline
17th Oct 202211:05 amRNSNotification of Major Holdings
12th Oct 20224:41 pmRNSSecond Price Monitoring Extn
12th Oct 20224:35 pmRNSPrice Monitoring Extension
30th Sep 20227:00 amRNSInterim Results
29th Sep 202211:31 amRNSResults of Consent Solicitation with Bondholders
15th Sep 20228:37 amRNSChange in Director’s Particulars
15th Sep 20227:00 amRNSUpdate to release date of 2022 Half-Year Results
7th Sep 20223:55 pmRNSConsent solicitation with Noteholders
31st Aug 20228:55 amRNSVoting Rights and Capital
29th Jul 202210:01 amRNSVoting Rights and Capital
29th Jul 20227:46 amRNSFCA Regulation
20th Jul 20229:00 amRNSDignity Announces Aim to be Net Zero By 2038
30th Jun 20224:50 pmRNSVoting Rights and Capital
17th Jun 20227:25 amRNS“intending to authorise” status from the FCA
14th Jun 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
9th Jun 20223:12 pmRNSBoard Update
9th Jun 202212:54 pmRNSResults of AGM
6th Jun 20227:00 amRNSNotification of Major Holdings
31st May 20227:00 amRNSVoting Rights and Capital
27th May 20222:52 pmRNSChange in Director’s Particulars
16th May 20227:00 amRNSAppointment of Chief Executive Officer
11th May 20227:00 amRNSFirst Quarter Trading Update
3rd May 202210:41 amRNSNotification of Major Holdings
29th Apr 20228:04 amRNS2021 Annual Report & Notice of 2022 AGM
29th Apr 20227:00 amRNSVoting Rights and Capital
14th Apr 202210:24 amRNSBLOCK LISTING SIX MONTHLY RETURN
4th Apr 202210:59 amRNSDirectorate Change
31st Mar 20227:00 amRNSTotal Voting Rights
30th Mar 202212:34 pmRNSNotification of Major Holdings
23rd Mar 20227:00 amRNSPreliminary Results
11th Mar 202211:49 amRNSResults of Bondholders Consent Solicitation
2nd Mar 20224:40 pmRNSSecond Price Monitoring Extn
2nd Mar 20224:35 pmRNSPrice Monitoring Extension
28th Feb 20227:00 amRNSVoting Rights and Capital
17th Feb 202210:30 amRNSTrading Update & Consent solicitation period
14th Feb 20227:00 amRNSNotification of Preliminary Results
12th Jan 202212:57 pmRNSBoard Appointment
7th Jan 20223:30 pmRNSBoard Appointments
31st Dec 20217:00 amRNSVoting Rights and Capital
17th Dec 20218:49 amRNSDirector Dealing Notification
14th Dec 202110:16 amRNSBLOCK LISTING SIX MONTHLY RETURN
30th Nov 20217:00 amRNSVoting Rights and Capital
8th Nov 20217:00 amRNSQ3 Trading Update
21st Oct 20217:00 amRNSAppointment of Joint Broker
14th Oct 20217:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
30th Sep 20217:00 amRNSVoting Rights and Capital
21st Sep 20217:00 amRNSInterim Results
1st Sep 20217:00 amRNSBoard Appointment
26th Jul 20217:00 amRNSBoard Appointment
12th Jul 20217:00 amRNSUpdate to release date of 2021 Half-Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.